Magnani John L.
SEC CIK 1589713 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CBIO | CRESCENT BIOPHARMA, INC. | CSO, SVP of Research | 366.1K | $52.7K | $3,517 | 2 | 2022-03-09 | 2022-11-11 |
Most active insiders at CBIO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Harwin Peter Evan | Dir, 10% | $18.24M | — |
| 2 | Fairmount Funds Management LLC | Dir, 10% | $12.38M | — |
| 3 | Brumm Joshua T | CEO, Dir | — | $920.8K |
| 4 | McNeill Jonathan | Pres, COO | — | $446.9K |
| 5 | Pinkas Jan | CSO | — | $34.9K |
| 6 | Im Ellie Eunkyung | Chief Medical Off | — | $33.1K |
| 7 | Bispham Barbara Harlin | See Remarks | — | $33.0K |
| 8 | Scalzo Richard William | CFO | — | $30.2K |
| 9 | Lynch Ryan | See Remarks | — | $12.7K |
| 10 | Doughty Christopher Grant | Chief Business Off | — | — |
Magnani John L. made no open-market trades at CBIO in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-14 | 2022-11-11 | CBIO | CRESCENT BIOPHARMA, INC. | Magnani John L. | CSO, SVP of Research | P - Purchase | $1.17 | +45.0K | 366.1K | +14% | +$52.7K | |
| 2022-03-10 | 2022-03-09 | CBIO | CRESCENT BIOPHARMA, INC. | Magnani John L. | CSO, SVP of Research | S - Sale | $1.09 | -3,227 | 321.0K | -1.0% | -$3,517 |
Purchase Sale Sale after option exercise All abbreviations